BlueScope Steel shares (ASX: BSL) fell 4.34% to A$30.66 today, extending the pullback that has gripped the stock since its full-year result in mid-August. The slide looks like the market continuing to re-price a stock that has delivered a blockbuster earnings year, a generous capital-return program and a rejected takeover approach, and is now being weighed against a more uncertain forward picture, without the dividend.
The stock moved ex-dividend on the day, with a payout of A$1.35 per share accounting for all but 55 cents of the day’s decline.
There has been a shift in narrative over recent weeks however. BlueScope’s FY26 numbers were striking: net profit of $802 million, up 857% on the prior year, and underlying EBIT of $1.27 billion, comfortably ahead of earlier guidance. North America was the engine, with EBIT doubling to $1.03 billion as tariffs and firm demand lifted US steel spreads, while Southeast Asia delivered a record $157 million.
But the domestic business told a different story, with Australian EBIT down 28% to $188 million as cheap Chinese steel exports and elevated energy costs squeezed margins. That split is now at the heart of the debate of how much of FY26’s earnings power is durable, and how much reflects a US spread cycle at or near its peak.
Management has framed FY27 as a transition year, guiding to first-half underlying EBIT of $860 million to $960 million with explicit caveats around spreads, currency and market conditions. For a stock that trades 34% higher over the past 12 months, that kind of language invites profit-taking. The company has signalled its intent to repeat the $3 per share framework in 2027, but the market appears focused on execution risk rather than the promise of returns.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
The fading takeover premium is another thread. Earlier this year BlueScope rejected a roughly $15 billion approach from SGH and Steel Dynamics at about $32.35 per share, arguing it undervalued the business. With management now emphasising organic value creation, some investors may be marking down the probability of a renewed bid, which puts the spotlight back on the cycle. Today’s close at $30.66 leaves the stock below that rejected bid level and under the mid-$33s zone where it traded after the result.
View From The Street
The average price target for BSL shares sits at $35.14, implying around 13.5% upside from today’s level. Looking ahead, potential risks could come from further evidence of Asian spread weakness, softer US pricing or slippage against the FY27 guidance range. On the upside, resilient US spreads, delivery of the additional $150 million in targeted FY27 cost benefits, progress at the Erskine Park coating line and clarity on energy contracting from late 2026 would support the case that FY26 was a reset to a higher earnings base, rather than a cyclical top.
Bull Case:
- FY26 underlying EBIT of $1.27 billion demonstrates genuine earnings power across regions.
- $3 per share returns framework signals strong cash generation and capital discipline.
- Consensus target of $35.14 implies roughly 13.5% upside from today’s price.
Bear Case:
- Australian EBIT fell 28% on cheap Chinese imports and elevated energy costs.
- FY27 framed as a transition year, with spread, FX and execution risks flagged.
- Fading takeover premium removes valuation support near the rejected $32.35 bid level.
